156 related articles for article (PubMed ID: 20195904)
21. New Molecular Markers Distinguishing Fonsecaea Agents of Chromoblastomycosis.
Schneider GX; Gomes RR; Bombassaro A; Zamarchi K; Voidaleski MF; Costa FF; Leão ACR; Lima BJFS; Soley BS; Colombo IR; Cândido GZ; Najafzadeh MJ; Sun J; de Azevedo CMPS; Marques SG; de Hoog GS; Vicente VA
Mycopathologia; 2019 Aug; 184(4):493-504. PubMed ID: 31317385
[TBL] [Abstract][Full Text] [Related]
22. Molecular phylogenetics of Fonsecaea strains isolated from chromoblastomycosis patients in South Korea.
Lim SW; Suh MK; Kang GS; Ha GY; Kim H; Choi JS; Kim YS
Mycoses; 2011 Sep; 54(5):e415-20. PubMed ID: 21910758
[TBL] [Abstract][Full Text] [Related]
23. Molecular ecology and pathogenic potential of Fonsecaea species.
De Hoog GS; Attili-Angelis D; Vicente VA; Van Den Ende AH; Queiroz-Telles F
Med Mycol; 2004 Oct; 42(5):405-16. PubMed ID: 15552642
[TBL] [Abstract][Full Text] [Related]
24. Secretion of five extracellular enzymes by strains of chromoblastomycosis agents.
Souza TF; Scroferneker ML; Costa JM; Carissimi M; Corbellini VA
Rev Inst Med Trop Sao Paulo; 2008; 50(5):269-72. PubMed ID: 18949343
[TBL] [Abstract][Full Text] [Related]
25. Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis.
de Andrade TS; Cury AE; de Castro LG; Hirata MH; Hirata RD
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):267-72. PubMed ID: 17338941
[TBL] [Abstract][Full Text] [Related]
26. [Two Cases of Chromomycosis Identified by Molecular Phylogenetic Analysis].
Mitomo T; Ushigome Y; Fukuda T; Kano Y; Shiohara T
Med Mycol J; 2016; 57(4):J133-J139. PubMed ID: 27904058
[TBL] [Abstract][Full Text] [Related]
27. Highly specific and sensitive, immunoblot-detected 54 kDa antigen from Fonsecaea pedrosoi.
Vidal MS; Castro LG; Cavalcante SC; Lacaz CS
Med Mycol; 2004 Dec; 42(6):511-5. PubMed ID: 15682639
[TBL] [Abstract][Full Text] [Related]
28. HIV Aspartic Peptidase Inhibitors Modulate Surface Molecules and Enzyme Activities Involved with Physiopathological Events in
Palmeira VF; Alviano DS; Braga-Silva LA; Goulart FRV; Granato MQ; Rozental S; Alviano CS; Santos ALS; Kneipp LF
Front Microbiol; 2017; 8():918. PubMed ID: 28579986
[No Abstract] [Full Text] [Related]
29. Chromoblastomycosis Caused by Fonsecaea pedrosoi.
Kim DM; Hwang SM; Suh MK; Ha GY; Choi GS; Shin J; Han SH
Ann Dermatol; 2011 Aug; 23(3):369-74. PubMed ID: 21909211
[TBL] [Abstract][Full Text] [Related]
30. Prolonged infection by Fonsecaea pedrosoi after antigenic co-stimulation at different sites in experimental murine chromoblastomycosis.
Machado AP; Silva MR; Fischman O
Virulence; 2010; 1(1):29-36. PubMed ID: 21178410
[TBL] [Abstract][Full Text] [Related]
31. Chromoblastomycosis in the Amazon region, Brazil, caused by Fonsecaea pedrosoi, Fonsecaea nubica, and Rhinocladiella similis: Clinicopathology, susceptibility, and molecular identification.
de Andrade TS; de Almeida AMZ; Basano SA; Takagi EH; Szeszs MW; Melhem MSC; Albuquerque M; Camargo JSAA; Gambale W; Camargo LMA
Med Mycol; 2020 Feb; 58(2):172-180. PubMed ID: 31329924
[TBL] [Abstract][Full Text] [Related]
32. Chromoblastomycosis due to Cladosporium langeronii. Molecular diagnosis of an agent previously diagnosed as Fonsecaea pedrosoi.
Torres-Guerrero E; Arenas R; Castro RH
An Bras Dermatol; 2018 Jun; 93(3):475-476. PubMed ID: 29924243
[No Abstract] [Full Text] [Related]
33. Fonsecaea pedrosoi Conidia Induces Activation of Dendritic Cells and Increases CD11c
Kimura TFE; Romera LMD; de Almeida SR
Mycopathologia; 2020 Apr; 185(2):245-256. PubMed ID: 32008205
[TBL] [Abstract][Full Text] [Related]
34. Extensive chromoblastomycosis caused by Fonsecaea pedrosoi successfully treated with a combination of amphotericin B and itraconazole.
Paniz-Mondolfi AE; Colella MT; Negrín DC; Aranzazu N; Oliver M; Reyes-Jaimes O; Pérez-Alvarez AM
Med Mycol; 2008 Mar; 46(2):179-84. PubMed ID: 18324498
[TBL] [Abstract][Full Text] [Related]
35. A case of chromoblastomycosis caused by Fonsecaea pedrosoi in a patient with rheumatoid arthritis.
Ohashi T; Ohtsuka M; Kikuchi N; Nishiyama K; Suzutani T; Yamamoto T
Int J Rheum Dis; 2015 Jun; 18(5):580-1. PubMed ID: 25293579
[No Abstract] [Full Text] [Related]
36. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea.
Najafzadeh MJ; Gueidan C; Badali H; Van Den Ende AH; Xi L; De Hoog GS
Med Mycol; 2009 Feb; 47(1):17-25. PubMed ID: 19107635
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin.
Bocca AL; Brito PP; Figueiredo F; Tosta CE
Mycopathologia; 2006 Apr; 161(4):195-203. PubMed ID: 16552481
[TBL] [Abstract][Full Text] [Related]
38. A case of chromomycosis caused by Fonsecaea pedrosoi and a review of reported cases of dematiaceous fungal infection in Japan.
Kondo M; Hiruma M; Nishioka Y; Mayuzumi N; Mochida K; Ikeda S; Ogawa H
Mycoses; 2005 May; 48(3):221-5. PubMed ID: 15842342
[TBL] [Abstract][Full Text] [Related]
39. Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis.
Vidal MS; de Castro LG; Cavalecate SC; Lacaz Cda S
Rev Inst Med Trop Sao Paulo; 2003; 45(6):315-8. PubMed ID: 14762630
[TBL] [Abstract][Full Text] [Related]
40. Septic arthritis and osteomyelitis due to the chromoblastomycosis agent Fonsecaea pedrosoi.
De Guzman L; Perlman DC; Hubbard CE
Am J Orthop (Belle Mead NJ); 2012 Jul; 41(7):328-31. PubMed ID: 22893884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
